Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nuvectis Pharma, Inc.

8.99
-0.2300-2.49%
Post-market: 8.990.00000.00%18:57 EDT
Volume:124.08K
Turnover:1.12M
Market Cap:210.29M
PE:-7.97
High:9.43
Open:9.19
Low:8.81
Close:9.22
Loading ...
Feb 13, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Nov 08, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 08, 2022

Major Issues Report

8-K - Current report
Aug 23, 2022

Correspondence

CORRESP [Cover] - Correspondence
Aug 15, 2022

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Aug 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2022

Major Issues Report

8-K - Current report
Jul 29, 2022

Major Issues Report

8-K - Current report
May 12, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 11, 2022

Major Issues Report

8-K - Current report
Mar 29, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Mar 28, 2022

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Mar 24, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 23, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 22, 2022

Major Issues Report

8-K - Current report
Feb 15, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 04, 2022

Major Issues Report

8-K - Current report
Feb 02, 2022

Correspondence

CORRESP [Cover] - Correspondence